We welcome the announcement that Polycystic Ovarian Syndrome, long known as PCOS, has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). This represents an important and positive step forward in women’s health.
The change reflects a growing understanding that this condition is far more complex than its previous name suggested, and that clearer language can help improve awareness, diagnosis, and care.
Why the Name Change Matters
The new name, PMOS, was developed through a rigorous global consensus process involving 56 academic, clinical and patient organisations, and more than 14,000 people living with PCOS and healthcare professionals worldwide.
This large-scale collaboration highlights just how significant this change is. It is not simply a rebrand – it is an effort to better align medical language with lived experience and current scientific understanding.
By removing the term “cysts” and instead highlighting the endocrine, metabolic, and ovarian aspects of the condition, PMOS helps shift the conversation in a more accurate and meaningful direction.
Moving Beyond the Word “Cysts”
One of the key reasons for the change is the misunderstanding caused by the original name.
Despite the term “polycystic ovarian syndrome,” not everyone with the condition has cysts on their ovaries, and having “polycystic-looking” ovaries on an ultrasound alone does not mean a person has the syndrome.
In fact, around 30% of women may have ovaries that appear polycystic on ultrasound without having PMOS.
This mismatch between name and reality has contributed to confusion, delayed diagnosis, and unnecessary anxiety for many women.
PMOS Is a Whole-Body Condition
The updated name better reflects what healthcare professionals now understand: PMOS is not just a reproductive condition.
It can affect multiple systems in the body, including:
- Hormonal balance
- Metabolism and insulin regulation
- Weight and energy levels
- Skin health (such as acne or excess hair growth)
- Fertility and reproductive health
- Mental health and emotional wellbeing
Importantly, these effects can occur regardless of whether polycystic ovaries are seen on ultrasound.
A Step Toward Better Care and Understanding
Renaming PCOS to PMOS is more than a terminology update — it is a step toward:
- Earlier and more accurate diagnosis
- Reduced stigma and misunderstanding
- Better communication between patients and clinicians
- More coordinated, whole-person care
For many women, this change may help validate their experience and support more meaningful conversations about symptoms and treatment options.
Language plays a powerful role in healthcare. When medical terms accurately reflect a condition, they can improve understanding, reduce confusion, and ultimately support better health outcomes.
The shift from PCOS to PMOS is a welcome move toward clearer, more inclusive, and more informed discussions about a complex condition that affects many aspects of women’s health.
If you have been diagnosed with PCOS in the past, your diagnosis and care remain valid. This change simply reflects an evolving understanding of the condition and how best to describe it moving forward.